`Gaps in knowledge' regarding depression relapse prevention

By  

Inpharma, Vol. 1, Iss. 1295, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

ECT in Parkinson's disease, with and without depression

By Trimble M.R.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 245-245

Elsevier

Access to resources Recommend Favorite

Pharmacotherapeutic approaches in relapse prevention

By Chick J.D.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 194-194

Elsevier

Access to resources Recommend Favorite

Use of Acamprosate and Different Kinds of Psychosocial Support in Relapse Prevention of Alcoholism: Results from a Non-Blind, Multicentre Study

By Soyka M.   Preuss U.   Schuetz C.  

Drugs in R&D, Vol. 3, Iss. 1, 2002-01 ,pp. : 1-12

Adis International

Access to resources Recommend Favorite

Relapse Prevention in Alcoholics: A Review of Acamprosate versus Naltrexone

By Hoes M.J.A.J.M.  

Clinical Drug Investigation, Vol. 17, Iss. 3, 1999-03 ,pp. : 211-216

Adis International

Access to resources Recommend Favorite